The document summarizes a literature review of clinical data for the Zynex Medical NeuroMove 900, an EMG-triggered neuromuscular electrical stimulation device. The review found evidence that equivalent devices were effective in improving function for stroke, spinal cord injury, and traumatic brain injury based on their similar intended use, method of application, patient populations, and critical performance characteristics. The NeuroMove 900 was determined to be clinically and technically equivalent to predicate devices like the AutoMove 800, indicating it is safe and effective for its intended use.